Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung CancerScott Gettinger, Julie R. Brahmer, Leora Horn et al.|Journal of Clinical Oncology|2015Cited by 1.2k
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesisYang Li, P. Charles Lin, Laura M. DeBusk et al.|Cancer Cell|2004Cited by 1.1k
Non-small-cell lung cancerCesare Gridelli, Rafael Rosell, Antônio Rossi et al.|Nature Reviews Disease Primers|2015Cited by 1.1k
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote MetastasisHoward H. Yang, Harold L. Moses, Jianhua Huang et al.|Cancer Cell|2008Cited by 917
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLCChristian Rolfo, David R. Gandara, Daniel Shao-Weng Tan et al.|Journal of Thoracic Oncology|2018Cited by 661